Day one and two after Sun Pharma snapped the Daiichi Sankyo-owned Ranbaxy for $4bn saw an outpouring of industry support for India's turnaround specialist and Sun's founder, Dilip Shanghvi.
written on 09.04.2014
Sun-Ranbaxy deal: Bouquets, Japan push and pay-scale concerns
